Back to top

Atrial Fibrillation Advance Programme evaluation

An evaluation of the Atrial Fibrillation Advance Programme in East Midlands

What we are doing:

The Atrial Fibrillation (AF) Advance Programme – East Midlands aims to prevent strokes through improved diagnosis and management of people with AF. The AF Advance Programme builds on the successful work undertaken by East Midlands Clinical Network in partnership with East Midlands Academic Health Science Network and the 19 Clinical Commissioning Groups (CCGs) in East Midlands between 2013-14 and 2016-17. This piece of work is intended to evaluate the programme during this implementation phase.

Why we are doing it:

East Midlands has a higher prevalence of atrial fibrillation than the national for England, 1.79% compared to 1.71% (March 2016). AF prevalence ranges from 0.94% in Leicester City CCG to 2.46% in Lincolnshire CCG.

Despite the improvements made within East Midlands to date, there are still a number of significant challenges to be met in stroke prevention in atrial fibrillation:

  • An estimated 36,183 AF patients are undiagnosed
  • Estimated prevalence is 120,428 (2.54%) compared to the diagnosed population as at March 2016 of 84,245 (1.79%). Across the East Midlands 70% of the estimated AF population are diagnosed 

What the benefits will be:

  • Increase the number of people who have been diagnosed with atrial fibrillation. 
  • This will lead to prevention of strokes and deaths
  • Admission costs avoidance

Who we are working with:

  • Health Education England
  • Heart Rhythm Alliance
  • Right Care
  • British Heart Foundation
  • Public Health England
  • The Stroke Organisation
  • East Midlands Academic Health Science Network (EM AHSN)

Study lead:

Name: Dr Sam Seidu

Role: Research Fellow

Organisation: Diabetes Research Centre, University of Leicester


Patrick Highton,